Search Results - "Kalafatis, D"

Identification of time-varying pH processes using sinusoidal signals by Kalafatis, Alex D., Wang, Liuping, Cluett, William R.

“…This paper presents an approach to the identification of time-varying, nonlinear pH processes based on the Wiener model structure. The algorithm produces an…”
Get full text

Identification of Wiener-type nonlinear systems in a noisy environment by Kalafatis, A. D., Wang, L., Cluett, W. R.

“…Wiener systems are widely encountered in engineering and science applications. This paper proposes a straightforward approach to the identification of Wiener…”
Get full text

Antifibrotic treatment in patients with Idiopathic pulmonary fibrosis (IPF): Real life data from a Swedish registry by Carlson, L, Kalafatis, D, Pesonen, I, Magnusson, J, Skold, M

Get full text

Rheumatoid Arthritis Related Antibodies in Idiopathic Pulmonary Fibrosis by Kalafatis, D, Joshua, V, Catrina, A, Hensvold, A, Skold, M

Get full text

Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry by Gao, Jing, Kalafatis, Dimitrios, Carlson, Lisa, Pesonen, Ida H A, Li, Chuan-Xing, Wheelock, Åsa, Magnusson, Jesper M, Sköld, C Magnus

“…Observational data under real-life conditions in idiopathic pulmonary fibrosis (IPF) is scarce. We explored anti-fibrotic treatment, disease severity and…”
Get full text

Presence of anti-modified protein antibodies in idiopathic pulmonary fibrosis by Kalafatis, Dimitrios, Joshua, Vijay, Hansson, Monika, Mathsson-Alm, Linda, Hensvold, Aase, Sköld, Magnus

“…Studies of autoimmunity and anti-citrullinated protein antibodies (ACPA) in idiopathic pulmonary fibrosis (IPF) have been confined to investigations of…”
Get full text

Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF by Kalafatis, Dimitrios, Lofdahl, Anna, Näsman, Per, Rendin, Linda Elowsson, Westergren-Thorsson, Gunilla, Skold, Magnus

Get full text

Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real‐world multicentre cohort by Durheim, Michael T., Bendstrup, Elisabeth, Carlson, Lisa, Sutinen, Eva M., Hyldgaard, Charlotte, Kalafatis, Dimitrios, Myllärniemi, Marjukka, Sköld, C. Magnus, Sjåheim, Tone

“…Background and objective Antifibrotic therapy with nintedanib or pirfenidone slows disease progression and reduces mortality in patients with idiopathic…”
Get full text

Brown dwarfs, quark stars, and quark-hadron phase transition by Cottingham, WN, Kalafatis, D, Vinh Mau R

“…It is shown that within an effective model of QCD, the Lee-Wick model, bodies with quark content of mass of the order of 10[sup [minus]2] to one solar mass can…”
Get full text

Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis by Kalafatis, Dimitrios, Löfdahl, Anna, Näsman, Per, Dellgren, Göran, Wheelock, Åsa M, Elowsson Rendin, Linda, Sköld, Magnus, Westergren-Thorsson, Gunilla

“…Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an unmet need of biomarkers that can aid in the diagnostic and prognostic…”
Get full text

Proteomic analysis in idiopathic pulmonary fibrosis with presence of anti-modified protein antibodies by Kalafatis, D, Joshua, V, Hansson, M, Mathsson-Alm, L, Elowsson, L, Westergren-Thorsson, G, Hensvold, A, Skold, M

Get full text

Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden by Kalafatis, Dimitrios, Gao, Jing, Pesonen, Ida, Carlson, Lisa, Sköld, C Magnus, Ferrara, Giovanni

“…Idiopathic pulmonary fibrosis (IPF) is a disease with poor prognosis mainly affecting males. Differences in clinical presentation between genders may be…”
Get full text

Autoantibodies in patients with idiopathic pulmonary fibrosis by Kalafatis, D, Pesonen, I, Carlson, L, Ferrara, G, Skold, M

Get full text

Cottingham, Kalafatis, and Vinh Mau reply by Cottingham, WN, Kalafatis, D, Vinh Mau R

Get full text

Cluster analysis and survival in patients with Idiopathic pulmonary fibrosis by Kalafatis, D, Carlson, L, Gao, J, Li, CX, Pesonen, I, Skold, CM

Get full text

Elevated leukocyte count predicts survival in patients with idiopathic pulmonary fibrosis: analysis from the Swedish and Japanese cohorts by Gao, J, Kalafatis, D, Iwamoto, H, Tanahashi, H, Yamaguchi, K, Horimasu, Y, Carlson, L, Pesonen, I, Hattori, N, Skold, M

Get full text

Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry by Gao, J, Kalafatis, D, Carlson, L, Li, CX, Pesonen, I, Skold, M

Get full text

Linearizing feedforward–feedback control of pH processes based on the Wiener model by Kalafatis, Alex D., Wang, Liuping, Cluett, William R.

“…This paper examines the control of pH processes based on the Wiener model construct (a dynamic linear element representing the mixing dynamics of the process…”
Get full text

Change in 6-minute walk test can predict prognosis in idiopathic pulmonary fibrosis by Gao, J, Kalafatis, D, Pesonen, I, Carlson, L, Giovanni, F, Skold, M

Get full text

Forced vital capacity, total lung capacity and diffusion capacity in idiopathic pulmonary fibrosis by Pesonen, I, Gao, J, Kalafatis, D, Carlson, L, Myllarniemi, M, Ferrara, G, Skold, M

Get full text